Loading organizations...

Digital healthcare solutions developer creating SaMD and DTx for life science companies, focused on chronic disease management.
Dawn Health is a Copenhagen, Denmark-based software developer that creates regulated digital healthcare solutions, specifically Software as Medical Devices and Digital Therapeutics, for international life science companies. The venture-backed enterprise operates a proprietary cloud-based platform designed to accelerate the development of chronic disease management applications targeting diabetes, growth hormone deficiency, oncology, and heart failure. Generating revenue through software licensing and development services, the organization currently maintains a workforce of 130 employees across its operations in Denmark, Germany, and the United Arab Emirates. The company has raised 37,430,000 dollars in total venture funding, including a recent 13,030,000 dollar Series A-II round, backed by lead investors Chr Augustinus Fabrikker, Vaekstfonden, and angel investor Lars Marcher. Founded in 2016 by Daniel Gewecke Daugaard, the Danish company is currently led by CEO Alexander Mandix Hansen and Chairman Lars Marcher.
Dawn Health has raised $2.0M across 2 funding rounds.
Dawn Health has raised $2.0M in total across 2 funding rounds.
Dawn Health has raised $2.0M in total across 2 funding rounds.
Dawn Health's investors include Cipio Partners, Chr. Augustinus Fabrikker, Export and Investment Fund, Trifork, Kindred Ventures, Alt Capital, B Capital Group, Will Wang, Convective Capital, HIVE Ventures, LGF, Moxxie Ventures.
Dawn Health is a Copenhagen‑based digital health company that builds regulated software-as-a-medical-device (SaMD) products and modular platforms to deliver digital therapeutics, therapy companions, and clinical-trial/patient‑support applications primarily for pharmaceutical and life‑science partners[1][5].[3]
High‑Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
Quick take: Dawn Health is a specialist B2B digital‑health product company that leverages certified processes, modular products and clinical/data capabilities to help pharma bring regulated digital therapeutics and patient‑support apps to market faster and at scale[1][5].
Dawn Health has raised $2.0M across 2 funding rounds. Most recently, it raised Venture Round in February 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 10, 2026 | Venture Round | Cipio Partners | Chr. Augustinus Fabrikker, Export and Investment Fund, Trifork |
| Feb 1, 2022 | $2.0M Seed | Kindred Ventures | Alt Capital, B Capital Group, Will Wang, Convective Capital, HIVE Ventures, LGF, Moxxie Ventures, Powerhouse Ventures, Saga, Scale Venture Partners, Scribble Ventures, Claire Hughes Johnson, Dylan Field, Kevin Lin, Mathilde Collin, Parker Conrad, Peter Fishman, Sam Altman, Sebastien Borget, Eoghan McCabe, Ilya Volodarsky, Bragiel Brothers, OnDeck |